Solesence, Inc. (SLSN)
NASDAQConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
$0.85-1.50%
Close 2026-09-04 · 1-day change
NASDAQConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
QuarterlyIQ Insights · SLSN
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 6 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $0.85, SLSN's earnings are too small for P/E to mean much; on sales it trades at 55× p/e (3.3× the 17× p/e peer median, and 0.9× even its own history). At a normal multiple the price implies ~108% near-term growth vs our ~-28% forecast. That gap is an optionality premium a financial-multiple model can't price — our $0.41 fair value covers only the as-is business, low confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| graham number | 12M | $0.25 | — | — | TTM | medium |
| Peer P/E | 12M | $0.26 | 16.8 | 0.02 | TTM | medium |
| Peer P/S | 12M | $0.67 | 0.9 | 0.78 | TTM | medium |
| residual income | 12M | $0.18 | — | — | TTM | medium |
| Own P/E history | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Only expensive valuation — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $0.93 |
| 60.2 |
| 0.02 |
| TTM |
| medium |
| triangulated | 12M | $0.26 | 16.8 | 0.02 | Triangulated | medium |
| Peer P/S | 3Y | $0.17 | 0.9 | 0.20 | guidance | medium |